A detailed history of Graypoint LLC transactions in Pfizer Inc stock. As of the latest transaction made, Graypoint LLC holds 36,617 shares of PFE stock, worth $979,138. This represents 0.07% of its overall portfolio holdings.

Number of Shares
36,617
Previous 32,765 11.76%
Holding current value
$979,138
Previous $916,000 15.61%
% of portfolio
0.07%
Previous 0.06%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$27.7 - $31.39 $106,700 - $120,914
3,852 Added 11.76%
36,617 $1.06 Million
Q2 2024

Jul 31, 2024

BUY
$25.26 - $29.6 $14,297 - $16,753
566 Added 1.76%
32,765 $916,000
Q1 2024

May 02, 2024

SELL
$25.89 - $29.73 $35,236 - $40,462
-1,361 Reduced 4.06%
32,199 $893,000
Q4 2023

Jan 29, 2024

SELL
$26.13 - $33.94 $411,939 - $535,064
-15,765 Reduced 31.96%
33,560 $966,000
Q3 2023

Oct 26, 2023

SELL
$32.09 - $37.51 $34,978 - $40,885
-1,090 Reduced 2.16%
49,325 $1.64 Million
Q2 2023

Jul 21, 2023

SELL
$36.12 - $41.79 $122,446 - $141,668
-3,390 Reduced 6.3%
50,415 $1.85 Million
Q1 2023

May 02, 2023

SELL
$39.39 - $51.28 $298,339 - $388,394
-7,574 Reduced 12.34%
53,805 $2.2 Million
Q4 2022

Jan 31, 2023

SELL
$41.75 - $54.5 $145,373 - $189,769
-3,482 Reduced 5.37%
61,379 $3.15 Million
Q3 2022

Oct 31, 2022

BUY
$43.76 - $53.42 $219,937 - $268,488
5,026 Added 8.4%
64,861 $2.84 Million
Q2 2022

Aug 01, 2022

SELL
$46.53 - $55.17 $75,657 - $89,706
-1,626 Reduced 2.65%
59,835 $3.14 Million
Q1 2022

Apr 19, 2022

BUY
$45.75 - $56.69 $358,314 - $443,996
7,832 Added 14.6%
61,461 $3.18 Million
Q4 2021

Jan 31, 2022

BUY
$41.32 - $61.25 $152,057 - $225,400
3,680 Added 7.37%
53,629 $3.17 Million
Q3 2021

Nov 09, 2021

BUY
$39.25 - $50.42 $52,909 - $67,966
1,348 Added 2.77%
49,949 $2.15 Million
Q2 2021

Aug 04, 2021

SELL
$35.91 - $40.68 $31,421 - $35,595
-875 Reduced 1.77%
48,601 $1.9 Million
Q1 2021

May 07, 2021

SELL
$33.49 - $37.77 $179,071 - $201,956
-5,347 Reduced 9.75%
49,476 $1.79 Million
Q4 2020

Feb 05, 2021

SELL
$33.47 - $42.56 $173,240 - $220,290
-5,176 Reduced 8.63%
54,823 $2.02 Million
Q3 2020

Nov 02, 2020

SELL
$31.75 - $37.25 $198,628 - $233,036
-6,256 Reduced 9.44%
59,999 $2.2 Million
Q2 2020

Jul 30, 2020

BUY
$30.12 - $36.54 $43,433 - $52,690
1,442 Added 2.22%
66,255 $2.06 Million
Q1 2020

Apr 30, 2020

BUY
$27.03 - $38.62 $1.75 Million - $2.5 Million
64,813 New
64,813 $2.12 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Graypoint LLC Portfolio

Follow Graypoint LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graypoint LLC, based on Form 13F filings with the SEC.

News

Stay updated on Graypoint LLC with notifications on news.